Liqiang Wu

1.2k total citations
85 papers, 955 citations indexed

About

Liqiang Wu is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Liqiang Wu has authored 85 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Organic Chemistry, 25 papers in Molecular Biology and 20 papers in Toxicology. Recurrent topics in Liqiang Wu's work include Multicomponent Synthesis of Heterocycles (27 papers), Synthesis and biological activity (25 papers) and Bioactive Compounds and Antitumor Agents (20 papers). Liqiang Wu is often cited by papers focused on Multicomponent Synthesis of Heterocycles (27 papers), Synthesis and biological activity (25 papers) and Bioactive Compounds and Antitumor Agents (20 papers). Liqiang Wu collaborates with scholars based in China and United States. Liqiang Wu's co-authors include Fulin Yan, Chunguang Yang, Chong Zhang, Weilin Li, Xiao Wang, Xin Ma, Limin Yang, Lizhen Fang, Weiwei Ma and Junhua Luo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Small.

In The Last Decade

Liqiang Wu

84 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liqiang Wu China 18 676 272 127 85 83 85 955
Martin Hein Germany 19 691 1.0× 295 1.1× 49 0.4× 28 0.3× 38 0.5× 70 954
Xian‐Li Ma China 17 550 0.8× 164 0.6× 157 1.2× 10 0.1× 41 0.5× 47 770
Mostafa A. Hussein Egypt 17 501 0.7× 133 0.5× 46 0.4× 20 0.2× 28 0.3× 42 703
Candace Crogan‐Grundy United States 14 1.1k 1.7× 315 1.2× 78 0.6× 277 3.3× 367 4.4× 17 1.6k
Long Min China 18 554 0.8× 189 0.7× 16 0.1× 27 0.3× 112 1.3× 37 867
Zhiwei Chen China 20 854 1.3× 138 0.5× 17 0.1× 33 0.4× 127 1.5× 97 1.2k
G. Mariappan India 12 328 0.5× 204 0.8× 34 0.3× 20 0.2× 28 0.3× 28 636
Jianqiang Qian China 14 180 0.3× 200 0.7× 22 0.2× 87 1.0× 40 0.5× 27 458
Jincheng Yang China 13 156 0.2× 214 0.8× 32 0.3× 127 1.5× 27 0.3× 38 583
Ankit Kumar Singh India 13 361 0.5× 264 1.0× 30 0.2× 22 0.3× 24 0.3× 47 750

Countries citing papers authored by Liqiang Wu

Since Specialization
Citations

This map shows the geographic impact of Liqiang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqiang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqiang Wu more than expected).

Fields of papers citing papers by Liqiang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqiang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqiang Wu. The network helps show where Liqiang Wu may publish in the future.

Co-authorship network of co-authors of Liqiang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Liqiang Wu. A scholar is included among the top collaborators of Liqiang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqiang Wu. Liqiang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao-jie, Tong, Tong Shen, Song Li, & Liqiang Wu. (2025). Design, synthesis, and biological evaluation of novel CDK4/6 and BRD4 dual inhibitors for treatment of KRAS-mutant NSCLC. European Journal of Medicinal Chemistry. 292. 117685–117685.
2.
Ding, Ran, et al.. (2025). Discovery of novel JQ1 derivatives as dual ferroptosis and apoptosis inducers for the treatment of triple-negative breast cancer. European Journal of Medicinal Chemistry. 286. 117275–117275. 1 indexed citations
3.
Jia, Shuting, et al.. (2024). Discovery of potent and novel dual NAMPT/BRD4 inhibitors for efficient treatment of hepatocellular carcinoma. European Journal of Medicinal Chemistry. 271. 116444–116444. 2 indexed citations
4.
Yang, Limin, Ran Ding, Tong Xiao-jie, et al.. (2024). Discovery of cloxiquine derivatives as potent HDAC inhibitors for the treatment of melanoma via activating PPARγ. European Journal of Medicinal Chemistry. 281. 117029–117029. 1 indexed citations
5.
Yang, Xiaojuan, Liqiang Wu, & Shaohong Xu. (2024). An overview of GPX4-targeting TPDs for cancer therapy. Bioorganic & Medicinal Chemistry. 118. 118046–118046. 3 indexed citations
6.
Li, Shunji, Jingxuan Liu, Xing Wang, et al.. (2024). Fully Integrated and High‐Throughput Microfluidic System for Multiplexed Point‐Of‐Care Testing. Small. 20(43). e2401848–e2401848. 18 indexed citations
7.
Li, Jian, et al.. (2023). Design, synthesis, and biological evaluation of quinolinedione-linked sulfonylpiperazine derivatives as NQO1-directed antitumor agents. Bioorganic Chemistry. 132. 106385–106385. 6 indexed citations
8.
Zhang, Chong, Limin Yang, Xiaojuan Yang, et al.. (2023). Design, synthesis, and biological evaluation of novel napabucasin-melatonin hybrids as potent STAT3 inhibitors. Bioorganic Chemistry. 136. 106541–106541. 11 indexed citations
9.
Ma, Xin, et al.. (2022). Recent advances in combretastatin A-4 codrugs for cancer therapy. European Journal of Medicinal Chemistry. 241. 114660–114660. 23 indexed citations
10.
Zhang, Xiuxia, Junhua Luo, & Liqiang Wu. (2022). FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer. Frontiers in Genetics. 13. 913659–913659. 38 indexed citations
11.
Wu, Liqiang, Xin Ma, & Zhaopeng Liu. (2021). Design, synthesis, and biological evaluation of 3-(1-benzotriazole)-nor-β-lapachones as NQO1-directed antitumor agents. Bioorganic Chemistry. 113. 104995–104995. 7 indexed citations
12.
Zhang, Chong, Yan Qu, Xin Ma, et al.. (2020). NQO1-selective activated prodrugs of combretastatin A-4: Synthesis and biological evaluation. Bioorganic Chemistry. 103. 104200–104200. 20 indexed citations
13.
Zhang, Chong, et al.. (2020). Synthesis and biological evaluation of NQO1-activated prodrugs of podophyllotoxin as antitumor agents. Bioorganic & Medicinal Chemistry. 28(24). 115821–115821. 23 indexed citations
14.
Wu, Liqiang, et al.. (2020). Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents. European Journal of Medicinal Chemistry. 198. 112396–112396. 21 indexed citations
15.
Candiotti, Keith, et al.. (2017). Octreotide protects against hepatic ischemia/reperfusion injury via HO-1-mediated autophagy. Acta Biochimica et Biophysica Sinica. 50(3). 316–318. 19 indexed citations
16.
Wu, Liqiang, et al.. (2014). Synthesis and antiproliferative evaluation of 13-aryl-13H-benzo[g]benzothiazolo [2,3-b]quinazoline-5,14-diones. Bioorganic & Medicinal Chemistry Letters. 24(6). 1462–1465. 18 indexed citations
17.
Wu, Liqiang, et al.. (2012). Sulfonic acid functionalized nano γ-Al2O3 catalyzed per-O-acetylated of carbohydrates. Carbohydrate Research. 365. 14–19. 26 indexed citations
18.
Liu, Shanshan, Zhihao Guo, Yaqin Wang, Tianbao Wang, & Liqiang Wu. (2011). Trichloroisocyanuric Acid as a Novel and Versatile Reagent for the Rapid α-Thiocyanation of Ketones. Bulletin of the Korean Chemical Society. 32(10). 3760–3762. 9 indexed citations
19.
Wang, Xingfen, et al.. (2010). ESTs analysis of suppression subtractive hybridization library from a upland cotton resistant cultivar infected by Verticillium dahliae.. Mianhua xuebao. 22(1). 17–22. 7 indexed citations
20.
Wu, Liqiang, et al.. (2008). Mann-Kendall Examination and Application in the Analysis of Precipitation Trend. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Hein Breakdown of academic impact, for papers by Xian‐Li Ma Breakdown of academic impact, for papers by Mostafa A. Hussein Breakdown of academic impact, for papers by Candace Crogan‐Grundy Breakdown of academic impact, for papers by Long Min Breakdown of academic impact, for papers by Zhiwei Chen Breakdown of academic impact, for papers by G. Mariappan Breakdown of academic impact, for papers by Jianqiang Qian Breakdown of academic impact, for papers by Jincheng Yang Breakdown of academic impact, for papers by Ankit Kumar Singh
Rankless by CCL
2026